228 related articles for article (PubMed ID: 19540999)
1. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
Mondok A; Varga I; Glaz E; Szucs N; Tóth M; Patocs A; Beko G; Racz K
Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
[TBL] [Abstract][Full Text] [Related]
2. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
3. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease.
Ahmed A; Saksena S; Sherlock M; Olliff SP; Elias E; Stewart PM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):898-903. PubMed ID: 18031327
[TBL] [Abstract][Full Text] [Related]
4. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity.
Frajese GV; Taylor NF; Jenkins PJ; Besser GM; Monson JP
Horm Res; 2004; 61(5):246-51. PubMed ID: 15004437
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
7. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
[TBL] [Abstract][Full Text] [Related]
8. Urinary free cortisol is not a biochemical marker of hypertension.
Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
[TBL] [Abstract][Full Text] [Related]
9. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
[TBL] [Abstract][Full Text] [Related]
10. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
[TBL] [Abstract][Full Text] [Related]
11. Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.
Sjöstrand M; Jansson PA; Palming J; de Schoolmeester J; Gill D; Rees A; Sjögren L; Persson T; Eriksson JW
Horm Metab Res; 2010 Oct; 42(11):798-802. PubMed ID: 20514603
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis.
Claus R; Wagner A; Lambert T
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111
[TBL] [Abstract][Full Text] [Related]
14. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity.
Basu R; Edgerton DS; Singh RJ; Cherrington A; Rizza RA
Diabetes; 2006 Nov; 55(11):3013-9. PubMed ID: 17065337
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG
Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
[TBL] [Abstract][Full Text] [Related]
18. Evidence for change of 11beta-hydroxysteroid dehydrogenase activity during infancy and childhood.
Dötsch J; Hohenberger I; Peter M; Sippell W; Dörr HG
Pediatr Res; 2000 Nov; 48(5):697-700. PubMed ID: 11044494
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone excess and the effect of octreotide in cats with diabetes mellitus.
Slingerland LI; Voorhout G; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2008 Nov; 35(4):352-61. PubMed ID: 18801640
[TBL] [Abstract][Full Text] [Related]
20. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]